BTG3 and familial pancreatic carcinoma: On the other hand, analysis of the same datasets did not support a relation of the BTG3/HIF1A ratios with patient survival in prostate and lung cancers, but showed a marginal effect in pancreatic cancer (Fig. S5), consistent with our result that BTG3 did not have an obvious impact on HIF1A RNA expression (Fig. 2a).